Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats ; volume:01 ; number:02 ; year:2016 ; pages:106-110
Journal of reconstructive microsurgery open ; 01, Heft 02 (2016), 106-110
- Beteiligte Personen und Organisationen
-
Vieira, Fabio Antonio
Fernandes, Marcela
Valente, Sandra Gomes
Nakachima, Luis Renato
Fernandes, Carlos Henrique
Dos Santos, João Baptista Gomes
- DOI
-
10.1055/s-0036-1593403
- URN
-
urn:nbn:de:101:1-2018112112572090827974
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vieira, Fabio Antonio
- Fernandes, Marcela
- Valente, Sandra Gomes
- Nakachima, Luis Renato
- Fernandes, Carlos Henrique
- Dos Santos, João Baptista Gomes
Ähnliche Objekte (12)
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19